BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement With VITARRAY Global Pte. Ltd. Focusing On The Provision Of MRNA Dynamic Gene Detection Services For The Southeast Asian Market
BioNexus Gene Lab Corp. Signs Strategic Outsourcing Agreement With VITARRAY Global Pte. Ltd. Focusing On The Provision Of MRNA Dynamic Gene Detection Services For The Southeast Asian Market
BioNexus Gene Lab Corp. (NASDAQ:BGLC, the "Company"))))), an emerging biotechnology company focused on innovative healthcare solutions, is pleased to announce that its wholly owned subsidiary, MRNA Scientific Sdn. Bhd. ("MRNA Scientific"), has entered into a strategic outsourcing agreement with VITARRAY Global Pte. Ltd. ("Vitarray"), an exempted private company incorporated in Singapore. This agreement focuses on the provision of mRNA dynamic gene detection services for the Southeast Asian market.
BioNexus Gene Lab corp（納斯達克：BGLC，"公司"）是一家新興的生物技術公司，專注於創新的醫療解決方案。該公司很高興地宣佈，其全資子公司MRNA Scientific私人有限責任公司（"MRNA Scientific"）已與全球貨幣VITARRAY私人有限責任公司（"Vitarray"）簽訂戰略外包協議。該協議重點關注爲東南亞市場提供mRNA動態基因檢測服務。
Under this agreement, MRNA Scientific will leverage its advanced medical testing facilities located in Kuala Lumpur, Malaysia, to provide outsourcing services for Vitarray's mRNA gene detection activities. This collaboration is aimed at enhancing the deployment of advanced molecular diagnostics throughout Southeast Asia, facilitating early disease detection and expanding access to innovative healthcare technologies.
根據該協議，MRNA Scientific將利用其位於馬來西亞吉隆坡的先進醫療測試設施，爲Vitarray的mRNA基因檢測活動提供外包服務。此次合作旨在加強在東南亞地區的先進分子診斷的應用，促進早期疾病檢測，並擴大對創新醫療技術的獲取。
譯文內容由第三人軟體翻譯。
